Latest News about FDA
Recent news which mentions FDA
Substance Use Disorder Company Narrows Q2 Net Loss, Reports Progress On Cannabinoid Intoxication Drug
February 14, 2024
From Benzinga
US Police Seizures Of Psychedelic Mushrooms Increased In Recent Years, New Study Finds
February 12, 2024
From Benzinga
From Benzinga
Why Is Inherited Rare Disease Focused-Larimar Therapeutics Stock Trading Lower Today?
February 12, 2024
From Benzinga
FDA Advisors Set To Discuss Abbott's TriClip For Heart Valve Disorder As Questions On Pivotal Trial Loom
February 12, 2024
From Benzinga
From Benzinga
Catalent's Bloomington Plant Making Novo Nordisk's Obesity Drug Faces FDA Scrutiny Regarding Drug Manufacturing Concerns
February 07, 2024
From Benzinga
Chikungunya Vaccine Maker Valneva Secures Non Dilutive Funding To Develop/Expand Its Clinical Pipeline
February 05, 2024
From Benzinga
FDA Approves Hemp Meal For Hen Feed, NH Eyes Private Cannabis Sales Model, CT Flower Shortage And More
February 01, 2024
From Benzinga
Why Obesity-Drug Maker NeuroBo Stock Is Trading Higher
February 01, 2024
From Benzinga
FDA Hosts Public Psychedelics Discussion, Discloses Major Growth On Number Of New Psychiatric Drugs Filings Post-2000
January 31, 2024
From Benzinga
Pfizer's COVID-19 Treatment Paxlovid Will No Longer Be Available For Emergency Use After This Date, FDA Revises Label
January 29, 2024
From Benzinga
Dutch Health Tech Firm Philips Stops US Sales Of Respiratory Devices Under Finalized Consent Decree Over Device Recall
January 29, 2024
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.